Valuation: Proteome Sciences plc

Market Cap 5.09M 6.77M 6.07M 5.61M 9.5M 643M 9.62M 67.24M 26.7M 337M 25.4M 24.86M 1.07B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.07M 26.71M 23.97M 22.14M 37.52M 2.54B 37.98M 265M 105M 1.33B 100M 98.13M 4.22B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 week+7.41%
Current month-0.34%
1 month+9.43%
3 months-23.68%
6 months-2.68%
Current year-42.00%
1 week 1.21
Extreme 1.21
1.68
1 month 1.2
Extreme 1.2
1.7
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
6.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
10
Manager TitleAgeSince
Corporate Officer/Principal - 2017-03-31
Corporate Secretary - 2017-07-31
Director TitleAgeSince
Chairman 73 2014-06-29
Director/Board Member 62 2009-12-31
Director/Board Member 64 2014-10-15
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+7.41%-35.56%-77.08% 6.77M
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
-2.31%+2.30%-44.00%+5.66% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.17%-0.34%+10.87%+84.40% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.87%+1.93%-4.14%-9.75% 33.59B
Average -0.86%+2.79%-12.56%+15.90% 75.1B
Weighted average by Cap. -0.82%+2.37%-13.40%+23.93%

Financials

2024 2025
Net sales 4.89M 6.5M 5.84M 5.39M 9.13M 618M 9.25M 64.61M 25.66M 324M 24.41M 23.89M 1.03B 3.76M 5M 4.49M 4.14M 7.02M 475M 7.11M 49.66M 19.72M 249M 18.76M 18.36M 789M
Net income -3.41M -4.53M -4.07M -3.76M -6.37M -431M -6.44M -45.03M -17.88M -226M -17.01M -16.65M -716M -3.06M -4.07M -3.66M -3.38M -5.72M -387M -5.79M -40.47M -16.07M -203M -15.29M -14.96M -643M
Net Debt 13.39M 17.82M 16M 14.77M 25.03M 1.69B 25.34M 177M 70.33M 887M 66.9M 65.47M 2.81B 14.99M 19.95M 17.9M 16.53M 28.01M 1.89B 28.36M 198M 78.7M 993M 74.87M 73.27M 3.15B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
26-10-27 GBX 1.450 0.00% 80,973
26-10-26 GBX 1.450 +7.81% 9,133
26-10-23 GBX 1.345 0.00% 20,585
26-10-22 GBX 1.345 0.00% 68
26-10-21 GBX 1.345 -0.37% 251,201